| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
| Exchange | NASDAQ |
| Div & Yield | N.A. (N.A) |
Latest News
SYNERGETICS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Synergetics USA, Inc. (SURG) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergetics USA, Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Valeant Pharmaceuticals International, Inc.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Synergetics USA, Inc.
SYNERGETICS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces The Investigation Of Synergetics USA, Inc. (SURG) Over The Proposed Sale Of The Company To Valeant Pharmaceuticals
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.
SHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Synergetics USA, Inc. And Encourages Investors To Contact The Firm For Additional Information
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Synergetics USA, Inc. Of Commencement Of An Investigation Concerning The Fairness Of The Sale Of The Company To Valeant Pharmaceuticals International, Inc.
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Synergetics USA, Inc.
SYNERGETICS USA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Valeant Pharmaceuticals International, Inc.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Synergetics USA,...
Kendall Law Group Investigates Whether Synergetics USA, Inc. Acquisition By Valeant Pharmaceuticals International, Inc. Is In Best Interest Of Synergetics Shareholders
Kendall Law Group, led by former federal judge Joe Kendall, is investigating Synergetics USA, Inc.
Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant
Synergetics USA (SURG) shares are spiking after the company was acquired by Valeant Pharmaceuticals (VRX) for $166 million today.
SYNERGETICS USA ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Launches An Investigation Into The Proposed Sale Of Synergetics USA, Inc.; Encourages Investors To Contact The Firm For Additional Information
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Synergetics USA, Inc.
Synergetics USA Enters Oversold Territory (SURG)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Why Synergetics (SURG) Stock Is Lower Today
Synergetics (SURG) stock is on the decline after reporting lower profit for its third quarter.
Faruqi & Faruqi, LLP Launches An Investigation Against Synergetics USA, Inc. (SURG) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.
4 Health Care Stocks Under $10 to Watch
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Synergetics USA Inc. Stock Downgraded (SURG)
Synergetics USA (Nasdaq:SURG) has been downgraded by TheStreet Ratings from from a buy to hold.
Synergetics USA To Present At Sidoti & Company Semi-Annual New York Micro Cap Conference
Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.
Synergetics Reports Record First Quarter
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales, gross...
Synergetics USA To Strengthen Independent Board Representation
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced that it plans to strengthen ...
Synergetics USA To Webcast Presentation At Stephens, Inc. Fall Investment Conference
Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.
Synergetics USA Announces New Vitrectomy Products At American Academy Of Ophthalmology 2011 Annual Meeting
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced two new ophthalmic products ...
Synergetics USA Inc. (SURG): Today's Featured Health Care Winner
Synergetics USA Inc was a winner within the health care sector, rising 5 cents (0.8%) to $6.11 on heavy volume.